BLFS · Biolife Solutions Inc
$35.07
-0.16 (-0.45%)
At close · Aug 14
Market Cap
$1.72B
Shares
48.91M
Biolife Solutions Inc Earnings Call Transcripts
Every quarterly earnings call for Biolife Solutions Inc (BLFS) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲20.6%
$40.75M
−$10.32M
'22 Q3
22-11-09
▼210.6%
$
−$49.19M
'22 Q4
23-03-16
▲4.1%
$37.70M
−$13.71M
'23 Q1
23-05-10
▼27.9%
$29.24M
−$10.20M
'23 Q2
23-08-08
▼42.1%
$23.57M
−$29.13M
'23 Q3
23-10-23
·
$
−$14.96M
'23 Q4
24-01-08
▼51.1%
$18.43M
−$10.22M
'24 Q1
24-05-09
▼32.6%
$19.71M
−$20.72M
'24 Q2
24-08-08
▼9.3%
$21.39M
−$1.70M
'24 Q3
24-11-12
·
$15.11M
$12.46M
'24 Q4
24-12-31
▲19.6%
$22.05M
−$448,000
'25 Q1
25-05-08
▲18.9%
$23.44M
−$15.84M
'25 Q2
25-08-07
▲31.2%
$28.07M
$621,000
'25 Q3
25-11-06
▲50%
$22.66M
$11.07M
'25 Q4
26-02-26
▲24.7%
$27.50M
$1.19M
'26 Q1
26-05-07
LATEST
▲21.5%
$28.47M
$45.10M
'26 Q2
26-08-06
Earnings call
FY26 · Q2
2026-08-06
Biolife Solutions Inc Q2 FY2026 Earnings Call
Revenue
$28.47M
▲ 21.5% YoY Diluted EPS
$0.91
Gross margin
64.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Biolife Solutions Inc Q1 FY2026 Earnings Call
Confident tone
Biopreservation Media (BPM) Growth
Homebrew Conversion Opportunity
Gross Margin / Bag Yield Issue
Revenue
$27.50M
▲ 24.7% YoY Diluted EPS
$0.02
Gross margin
63.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Biolife Solutions Inc Q4 FY2025 Earnings Call
Confident tone
Strategic Partnerships & M&A (Qkine, Panthera, Pluristics)
2026 Financial Guidance & Profitability
Cell & Gene Therapy (CGT) Market Opportunity
Revenue
$22.66M*
▲ 50% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Biolife Solutions Inc Q3 FY2025 Earnings Call
Confident tone
Cell processing revenue growth
Guidance raise and Q4 visibility
Customer mix shift to commercial and direct sales
Revenue
$28.07M
▲ 31.2% YoY Diluted EPS
$0.01
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Biolife Solutions Inc Q2 FY2025 Earnings Call
Confident tone
Strategic acquisitions and investments
Cell processing revenue growth
Raised full-year guidance
Revenue
$23.44M
▲ 18.9% YoY Diluted EPS
$-0.33
Gross margin
65.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Biolife Solutions Inc Q1 FY2025 Earnings Call
Confident tone
Cell processing platform growth
Commercial customer mix / revenue durability
Tariffs and trade policy risk
Revenue
$22.05M
▲ 19.6% YoY Diluted EPS
$0.00
Gross margin
67.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Biolife Solutions Inc Q4 FY2024 Earnings Call
Confident tone
Cell Processing platform growth
Product line expansion (Sxton consumables, CryoCase, CT5)
Profitability and margin expansion
Revenue
$15.11M*
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Biolife Solutions Inc Q3 FY2024 Earnings Call
Confident tone
Cell processing platform growth
SciSafe divestiture and portfolio streamlining
Margin expansion and profitability
Revenue
$21.39M
▼ 9.3% YoY Diluted EPS
$-0.04
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Biolife Solutions Inc Q2 FY2024 Earnings Call
Revenue
$19.71M
▼ 32.6% YoY Diluted EPS
$-0.45
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Biolife Solutions Inc Q1 FY2024 Earnings Call
Confident tone
GCI / CBS divestitures and portfolio rationalization
Cell processing / biopreservation media growth
Margin expansion and adjusted EBITDA
Revenue
$18.43M
▼ 51.1% YoY Diluted EPS
$-0.22
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-01-08
Biolife Solutions Inc Q4 FY2023 Earnings Call
Positive tone
Cell Processing Platform Performance
2024 Revenue Guidance
Freezer Divestiture
Revenue
$*
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-23
Biolife Solutions Inc Q3 FY2023 Earnings Call
Revenue
$23.57M
▼ 42.1% YoY Diluted EPS
$-0.67
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Biolife Solutions Inc Q2 FY2023 Earnings Call
Revenue
$29.24M
▼ 27.9% YoY Diluted EPS
$-0.23
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
Biolife Solutions Inc Q1 FY2023 Earnings Call
Revenue
$37.70M
▲ 4.1% YoY Diluted EPS
$-0.32
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-16
Biolife Solutions Inc Q4 FY2022 Earnings Call
Revenue
$*
▼ 210.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-09
Biolife Solutions Inc Q3 FY2022 Earnings Call
Revenue
$40.75M
▲ 20.6% YoY Diluted EPS
$-0.24
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
Biolife Solutions Inc Q2 FY2022 Earnings Call
Revenue
$40.53M
▲ 29.9% YoY Diluted EPS
$-1.72
▼ 1005.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
Biolife Solutions Inc Q1 FY2022 Earnings Call
Revenue
$36.22M
▲ 115% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-28
Biolife Solutions Inc Q4 FY2021 Earnings Call
Revenue
$37.30M*
▲ 153.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-12
Biolife Solutions Inc Q3 FY2021 Earnings Call
Revenue
$33.80M
▲ 199.7% YoY Diluted EPS
$0.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
Biolife Solutions Inc Q2 FY2021 Earnings Call
Revenue
$31.20M
▲ 214.6% YoY Diluted EPS
$0.19
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
Biolife Solutions Inc Q1 FY2021 Earnings Call
Revenue
$16.85M
▲ 38.5% YoY Diluted EPS
$-0.03
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-22
Biolife Solutions Inc Q4 FY2020 Earnings Call
Revenue
$14.73M*
▲ 77.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Biolife Solutions Inc Q3 FY2020 Earnings Call
Revenue
$11.28M
▲ 70.8% YoY Diluted EPS
$-0.04
▼ 111.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-02
Biolife Solutions Inc Q2 FY2020 Earnings Call
Revenue
$9.92M
▲ 48% YoY Diluted EPS
$-0.70
▼ 3600% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-14
Biolife Solutions Inc Q1 FY2020 Earnings Call
Revenue
$12.16M
▲ 110.8% YoY Diluted EPS
$-0.01
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-11
Biolife Solutions Inc Q4 FY2019 Earnings Call
Revenue
$8.30M*
▲ 52.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 earnings calls